FDA approves Celltrion's Herceptin biosimilar

FDA approves Celltrion's Herceptin biosimilar

Submitted by admin on December 16, 2018 - 12:23am
Source: 
BioCentury
News Tags: 
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
Headline: 
FDA approves Celltrion's Herceptin biosimilar
snippet: 

FDA approved a BLA for Herceptin biosimilar Herzuma trastuzumab-pkrb from Celltrion Inc. (KOSDAQ:068270) to treat HER2-positive breast cancer.

Do Not Allow Advertisers to Use My Personal information